Business Description
Aytu BioPharma Inc
NAICS : 541714
SIC : 2834
ISIN : US0547544033
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.22 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | 5.19 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -2.85 | |||||
Beneish M-Score | -2.85 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -35.9 | |||||
3-Year EBITDA Growth Rate | 73.1 | |||||
3-Year EPS without NRI Growth Rate | 61.6 | |||||
3-Year FCF Growth Rate | 77 | |||||
3-Year Book Growth Rate | -63.9 | |||||
Future 3-5Y Total Revenue Growth Rate | -12.88 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.95 | |||||
9-Day RSI | 50.16 | |||||
14-Day RSI | 48.53 | |||||
6-1 Month Momentum % | 5.84 | |||||
12-1 Month Momentum % | 26.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.11 | |||||
Quick Ratio | 0.91 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 130.15 | |||||
Days Sales Outstanding | 109.55 | |||||
Days Payable | 128.38 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -106.2 | |||||
Shareholder Yield % | -9.11 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 63.24 | |||||
Operating Margin % | -5.71 | |||||
Net Margin % | -18.27 | |||||
FCF Margin % | 6.21 | |||||
ROE % | -47.09 | |||||
ROA % | -13.06 | |||||
ROIC % | -6.67 | |||||
ROC (Joel Greenblatt) % | -135.7 | |||||
ROCE % | -8.32 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 5.85 | |||||
PS Ratio | 0.13 | |||||
PB Ratio | 0.5 | |||||
Price-to-Free-Cash-Flow | 1.99 | |||||
Price-to-Operating-Cash-Flow | 1.99 | |||||
EV-to-EBIT | -2.26 | |||||
EV-to-Forward-EBIT | -2.7 | |||||
EV-to-EBITDA | 4.1 | |||||
EV-to-Revenue | 0.13 | |||||
EV-to-Forward-Revenue | 0.16 | |||||
EV-to-FCF | 2.07 | |||||
Earnings Yield (Greenblatt) % | -44.25 | |||||
FCF Yield % | 37.52 |